Luyan Pharma Co.,Ltd.’s Net Profit Rose 10% in First Three Quarters of 2022

Luyan Pharma Co.,Ltd. (鹭燕医药股份有限公司) (002788.SZ) reported a net profit of 252 million yuan in the first three quarters of 2022, up 10% year-on-year.

Meanwhile, the company posted 14.3 billion yuan in revenue, up 10.2% year-on-year.

At the end of the reporting period, it had 10.8 billion yuan in total assets and 8.1 billion yuan in total liabilities, with a liability-to-asset ratio of 75%.